Abstract
Effects of the Cannabinoid-1 Receptor Blocker Rimonabant on Weight Reduction and Cardiovascular Risk Factors in Overweight Patients: 1-Year Experience From the RIO-Europe Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have